연구성과로 돌아가기
JCR 2024 저널 목록 (1229 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANNALI DELL ISTITUTO SUPERIORE DI SANITA | Istituto Superiore Sanita | 0021-2571 | 2384-8553 | SCIE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1,259 | 1.7 | Q3 | 62.9 | 37.1 | 264/419 | 1.8 | Q3 | 1.6 | 0.1 | 0.44 | 314/419 | Q3 | 25.18 | 0.001 | 0.165 | 0.440 | Q3 | 33 | 93.9% | 8.7 | 6.0 | 31 | 0.0% | 2025-08-05 16:05:00 | 바로가기 |
| Annals of Telecommunications | SPRINGER INT PUBL AG | 0003-4347 | 1958-9395 | SCIE | TELECOMMUNICATIONS | 993 | 2.2 | Q3 | 62.9 | 37.1 | 76/120 | 2.0 | Q3 | 2.2 | 0.6 | 0.48 | 77/120 | Q3 | 36.25 | 0.001 | 0.184 | 0.340 | Q3 | 55 | 92.7% | 4.6 | 5.4 | 51 | 17.5% | 2025-08-05 16:05:25 | 바로가기 |
| Annals of Transplantation | INT SCIENTIFIC INFORMATION, INC | 1425-9524 | N/A | SCIE | TRANSPLANTATION | 1,186 | 1.4 | Q3 | 62.9 | 37.1 | 20/31 | 1.3 | Q3 | 1.4 | 0.1 | 0.47 | 21/31 | Q3 | 33.87 | 0.001 | 0.214 | 0.364 | Q3 | 55 | 96.4% | 7.3 | 7.8 | 53 | 28.1% | 2025-08-05 16:05:27 | 바로가기 |
| Asia-Pacific Journal of Sport Medicine Arthroscopy Rehabilitation and Technology | ELSEVIER SINGAPORE PTE LTD | 2214-6873 | 2214-6873 | ESCI | ORTHOPEDICS | 369 | 1.4 | Q3 | 62.9 | 37.1 | 88/139 | 1.6 | Q3 | 1.4 | 0.2 | 0.60 | 88/139 | Q3 | 37.05 | 0.000 | 0.107 | 0.466 | Q3 | 33 | 100.0% | 5.1 | 8.8 | 33 | 100.0% | 2025-08-05 16:04:29 | 바로가기 |
| Berichte zur Wissenschaftsgeschichte | WILEY-V C H VERLAG GMBH | 0170-6233 | 1522-2365 | AHCI, SCIE, SSCI | HISTORY & PHILOSOPHY OF SCIENCE | 133 | 0.4 | Q3 | 62.9 | 37.1 | 71/112 | 0.6 | Q2 | 0.4 | <0.1 | 0.46 | 58/112 | Q3 | 48.66 | 0.000 | 0.093 | 0.436 | Q2 | 19 | 100.0% | 5.7 | 20.4 | 19 | 38.9% | 2025-08-05 16:03:27 | 바로가기 |
| Canadian Journal of Health History | UNIV TORONTO PRESS INC | 0823-2105 | 2371-0179 | ESCI | HISTORY & PHILOSOPHY OF SCIENCE | 11 | 0.4 | Q3 | 62.9 | 37.1 | 71/112 | 0.4 | Q3 | 0.4 | <0.1 | 0.27 | 84/112 | Q3 | 25.45 | 0.000 | 0.011 | 0.228 | Q3 | 8 | 100.0% | N/A | 32.8 | 8 | 0.0% | 2025-08-05 16:03:27 | 바로가기 |
| CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | MARY ANN LIEBERT, INC | 1084-9785 | 1557-8852 | SCIE | PHARMACOLOGY & PHARMACY | 2,258 | 2.1 | Q3 | 62.9 | 37.1 | 222/352 | 2.4 | Q3 | 2.0 | 0.2 | 0.56 | 208/353 | Q3 | 41.22 | 0.002 | 0.397 | 0.470 | Q3 | 61 | 93.4% | 5.8 | 6.1 | 57 | 5.3% | 2025-08-05 16:04:34 | 바로가기 |
| CLINICAL BIOMECHANICS | ELSEVIER SCI LTD | 0268-0033 | 1879-1271 | SCIE | ORTHOPEDICS | 9,451 | 1.4 | Q3 | 62.9 | 37.1 | 88/139 | 1.8 | Q3 | 1.3 | 0.3 | 0.52 | 97/139 | Q3 | 30.58 | 0.005 | 1.011 | 0.497 | Q3 | 167 | 96.4% | 13.0 | 9.5 | 161 | 14.5% | 2025-08-05 16:04:28 | 바로가기 |
| Clinical Epidemiology and Global Health | ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTD | 2452-0918 | 2213-3984 | ESCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 2,518 | 1.7 | Q3 | 62.9 | 37.1 | 264/419 | 2.1 | Q3 | 1.6 | 0.3 | 0.66 | 217/419 | Q3 | 48.33 | 0.004 | 0.865 | 0.454 | Q3 | 335 | 92.8% | 3.7 | 6.3 | 311 | 99.5% | 2025-08-05 16:05:00 | 바로가기 |
| COMMUNITY MENTAL HEALTH JOURNAL | SPRINGER | 0010-3853 | 1573-2789 | SSCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 4,658 | 1.7 | Q3 | 62.9 | 37.1 | 264/419 | 2.4 | Q3 | 1.6 | 0.4 | 0.61 | 234/419 | Q3 | 44.27 | 0.005 | 1.095 | 0.705 | Q2 | 170 | 98.8% | 6.4 | 7.5 | 168 | 30.3% | 2025-08-05 16:04:59 | 바로가기 |
| CRYPTOLOGIA | TAYLOR & FRANCIS INC | 0161-1194 | 1558-1586 | SCIE | HISTORY & PHILOSOPHY OF SCIENCE | 282 | 0.4 | Q3 | 62.9 | 37.1 | 71/112 | 0.6 | Q2 | 0.2 | 0.1 | 0.18 | 96/112 | Q4 | 14.73 | 0.000 | 0.032 | 0.132 | Q4 | 19 | 94.7% | 18.0 | 14.1 | 18 | 13.2% | 2025-08-05 16:03:27 | 바로가기 |
| Current Vascular Pharmacology | BENTHAM SCIENCE PUBL LTD | 1570-1611 | 1875-6212 | SCIE | PHARMACOLOGY & PHARMACY | 2,307 | 2.1 | Q3 | 62.9 | 37.1 | 222/352 | 3.9 | Q2 | 1.9 | 0.8 | 0.50 | 232/353 | Q3 | 34.42 | 0.002 | 0.379 | 0.836 | Q2 | 43 | 55.8% | 6.8 | 6.3 | 24 | 4.1% | 2025-08-05 16:04:34 | 바로가기 |
| DARU-Journal of Pharmaceutical Sciences | SPRINGER INT PUBL AG | N/A | 2008-2231 | SCIE | PHARMACOLOGY & PHARMACY | 2,204 | 2.1 | Q3 | 62.9 | 37.1 | 222/352 | 3.4 | Q2 | 2.1 | 0.4 | 0.62 | 195/353 | Q3 | 44.90 | 0.001 | 0.259 | 0.566 | Q3 | 53 | 66.0% | 8.1 | 6.7 | 35 | 10.3% | 2025-08-05 16:04:34 | 바로가기 |
| Drug Research | GEORG THIEME VERLAG KG | 2194-9379 | 2194-9387 | ESCI | PHARMACOLOGY & PHARMACY | 1,522 | 2.1 | Q3 | 62.9 | 37.1 | 222/352 | 1.9 | Q3 | 2.1 | 0.7 | 0.36 | 280/353 | Q4 | 20.82 | 0.001 | 0.187 | 0.306 | Q4 | 47 | 70.2% | 6.3 | 7.6 | 33 | 2.6% | 2025-08-05 16:04:35 | 바로가기 |
| DRUGS IN R&D | SPRINGER INT PUBL AG | 1174-5886 | 1179-6901 | SCIE | PHARMACOLOGY & PHARMACY | 1,230 | 2.1 | Q3 | 62.9 | 37.1 | 222/352 | 2.5 | Q3 | 2.0 | 0.3 | 0.61 | 198/353 | Q3 | 44.05 | 0.001 | 0.211 | 0.674 | Q2 | 46 | 91.3% | 7.5 | 9.4 | 42 | 100.0% | 2025-08-05 16:04:35 | 바로가기 |
페이지 이동: